Announcement
·
06 May 2025
·
M42 appoints Dimitris Moulavasilis as Group CEO
Learn More

A New Dawn in Fertility: Embracing Innovation in IVF

30 January 2024
Specialized Medical Fields

About the Speakers

  • Dr. Val Zvereff
    Laboratory Director at M42
  • Dr. Fawad Khan
    Program Lead of the Hereditary High Risk & Cancer Survivorship Programs at the Oncology Institute
  • Dr. Stephen Grobmyer
    Chairman of Oncology at Cleveland Clinic Abu Dhabi
  • Albarah El Khani
    Senior Director of Operations at M42

    Watch Next